Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid arthritis.

R C Williams

    Hospital Practice
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    The reasons for intermittent versus unrelenting joint destruction in patients are not fully understood. However, research is identifying distinct clinical courses to personalize treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Studies of antibody to herpes simplex virus Fc gamma-binding protein gE in patients with rheumatoid arthritis, juvenile rheumatoid arthritis and normal controls.

    Scandinavian journal of immunology·1992
    Same author

    Radiographic evaluation of crestal bone levels adjacent to nonsubmerged titanium implants.

    Clinical oral implants research·1992
    Same author

    Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same author

    Human anti-F(ab')2 antibodies show preferential reactivity for F(ab')2 molecules bearing lambda light chains.

    Clinical immunology and immunopathology·1992
    Same author

    Differential mapping of Fc gamma-binding and monoclonal antibody-reactive epitopes on gE, the Fc gamma-binding glycoprotein of herpes simplex virus type 1.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same author

    Heteroclitic polyclonal and monoclonal anti-Gm(a) and anti-Gm(g) human rheumatoid factors react with epitopes induced in Gm(a-), Gm(g-) IgG by interaction with antigen or by nonspecific aggregation. A possible mechanism for the in vivo generation of rheumatoid factors.

    Journal of immunology (Baltimore, Md. : 1950)·1992
    Same journal

    Cri du chat and Potter syndromes: a decision to abort.

    Hospital practice·1992
    Same journal

    Who decides when care is futile?

    Hospital practice·1991
    Same journal

    Withholding and withdrawing life support.

    Hospital practice·1991
    Same journal

    Of dead brains, living wills, and autonomy.

    Hospital practice·1991
    Same journal

    Partner notification for HIV control.

    Hospital practice·1990
    Same journal

    Promiscuity and public health: some clinical and ethical issues.

    Hospital practice·1990
    See all related articles

    Area of Science:

    • Rheumatology
    • Immunology
    • Pathophysiology

    Background:

    • Self-perpetuating joint destruction is a hallmark of several chronic rheumatic diseases.
    • The clinical course of joint destruction varies significantly among patients, ranging from intermittent to unrelenting progression.
    • Understanding these variations is crucial for effective disease management.

    Purpose of the Study:

    • To investigate the underlying factors contributing to the differential progression of joint destruction.
    • To identify distinct clinical phenotypes of joint disease based on disease course.
    • To inform the development of tailored therapeutic strategies for different patient subgroups.

    Main Methods:

    • Analysis of longitudinal patient data to characterize disease progression patterns.

    Related Experiment Videos

  • Identification of clinical and biological markers associated with intermittent versus unrelenting joint destruction.
  • Comparative analysis of treatment responses across different clinical courses.

    • Main Results:

    • Distinct patterns of joint destruction, characterized as intermittent or unrelenting, have been identified.
    • Specific clinical and/or biological factors may predict the disease course in some patients.
    • Preliminary evidence suggests differential efficacy of certain treatments based on the identified clinical courses.

    Conclusions:

    • The heterogeneity in joint destruction progression is a significant clinical challenge.
    • Identifying distinct clinical courses is a critical step towards personalized medicine in rheumatology.
    • Further research is needed to elucidate the mechanisms driving these different disease trajectories and optimize treatment selection.